Stock Price
P/E Ratio
Volume Traded Today
Dividend
52 Week High/low
Nutex Health, Inc. Market Cap
Based on ratings from 0 stock analysts, the Nutex Health, Inc. stock price is expected to increase by 108.24% in 12 months. This is calculated by using the average 12-month stock price forecast for Nutex Health, Inc.. The lowest target is $45 and the highest is $45. Please note analyst price targets are not guaranteed and could be missed completely.
Nutex Health, Inc. has a total of 0 Wall St Analyst ratings. There are 0 buy ratings, 0 ratings, and 0 sell ratings. Since most analysts have a sell consensus rating, the expectation is that Nutex Health, Inc. will perform worse than the market. Investors shouldn't rely purely on analyst ratings; we encourage investors to also take a look at the fundamental and technical analysis in their due diligence.
These are the latest 20 analyst ratings of NUTX.
|
Analyst/Firm |
Rating |
Price Target |
Change |
Date |
|---|---|---|---|---|
| Anthony Vendetti Maxim Group | Buy | $45 | Initiates | Sep 18, 2024 |
| Bill Sutherland Benchmark | Buy | $45 | Maintains | Aug 21, 2024 |
| Bill Sutherland Benchmark | Buy | $1 | Maintains | Jan 25, 2024 |
| Bill Sutherland Benchmark | Buy | $1.5 | Maintains | Nov 14, 2023 |
| Bill Sutherland Benchmark | Buy | $2.5 | Reiterates | Aug 29, 2023 |
| Bill Sutherland Benchmark | Buy | $2.5 | Maintains | May 17, 2023 |
| Bill Sutherland Benchmark | Buy | $3 | Reiterates | Mar 9, 2023 |
| Bill Sutherland Benchmark | Buy | $3 | Initiates | Dec 23, 2022 |
When did it IPO
2013
Staff Count
800
Country
United States
Sector/Industry
Healthcare/Health Information Services
CEO
Dr. Thomas T. Vo M.B.A., M.D.
Market Cap
$102.6M
In 2023, NUTX generated $247.6M in revenue, which was a increase of 12.93% from the previous year. This can be seen as a signal that NUTX's business is growing, and its share price could be worth more in the future. However, if the company grows faster (or slower) than expected, this could also have a major impact on the future share price.
Revenue From 2020
Revenue From 2021
Revenue From 2022
Revenue From 2023
Mon, 30 Sep 2024
Sentiment - NEUTRAL
Source - PRNewsWire
Summary - Nutex Health Inc. (NASDAQ: NUTX) announced that its micro hospitals received multiple community awards in Q3 2024, highlighting staff commitment to excellence in healthcare delivery.
Why It Matters - Awards and accolades enhance Nutex Health's reputation, potentially attracting more patients and increasing revenue, which can positively influence stock performance.
Mon, 26 Aug 2024
Sentiment - NEUTRAL
Source - PRNewsWire
Summary - Nutex Health Inc. (NASDAQ: NUTX) opened the Post Falls ER & Hospital in Idaho, expanding its network of 22 micro hospitals across 10 states, serving patients from Idaho and Washington.
Why It Matters - Nutex Health's expansion into Post Falls may enhance revenue and market share, signaling growth potential that can positively impact stock performance and attract investor interest.
Sat, 10 Aug 2024
Sentiment - NEUTRAL
Source - Seeking Alpha
Summary - Nutex Health (NASDAQ:NUTX) will hold its Q2 2024 earnings conference call on August 9, 2024, at 10:00 AM ET, featuring key executives including CEO Tom Vo and CFO Jon Bates.
Why It Matters - The Q2 2024 earnings call for Nutex Health provides insights into the company's financial performance and strategic direction, influencing investor sentiment and stock valuation.
Thu, 08 Aug 2024
Sentiment - NEUTRAL
Source - PRNewsWire
Summary - Nutex Health reported a 25% revenue increase to $143.5 million for H1 2024, with operating income up 140% to $33.3 million. Q2 revenue also rose 29% to $76.1 million.
Why It Matters - Nutex Health's revenue and operating income growth signals strong demand and effective management, boosting investor confidence and potential for future profitability.
Mon, 05 Aug 2024
Sentiment - NEUTRAL
Source - PRNewsWire
Summary - Nutex Health Inc. (NASDAQ: NUTX) will release Q2 2024 financial results on August 8, 2024, and discuss them in a conference call on August 9, 2024, at 10:00 am ET.
Why It Matters - Nutex Health's upcoming financial results announcement may impact stock performance, offering insights into its growth, profitability, and operational efficiency, crucial for investment decisions.
Mon, 29 Jul 2024
Sentiment - NEUTRAL
Source - PRNewsWire
Summary - Nutex Health Inc. (NASDAQ: NUTX) has regained compliance with Nasdaq's minimum bid price requirement after its stock traded above $1.00 post-reverse split from July 3 to July 23, 2024.
Why It Matters - Nutex Health's compliance with Nasdaq's minimum bid requirement enhances its credibility and stability, potentially attracting more investors and improving stock performance.
The information that Ticker Nerd provides is general in nature as it has been prepared without taking account of your objectives, financial situation or needs. It is not intended as legal, financial or investment advice and should not be construed or relied on as such. Ticker Nerd is for information purposes only. Ticker Nerd is not responsible for any damages or losses that may occur as a result of reliance on this information. Before making any commitment of a legal or financial nature you should seek advice from a qualified and registered legal practitioner or financial or investment adviser. All content, group, messaging, tweets, newsletter, article, and email created by Ticker Nerd is intended for educational and information purposes only, is not financial, investment, legal or tax advice, and is a restatement, summary or extract of other data and research reports that are widely distributed from sources such as, but not limited to, Bloomberg, Market Watch, Wall Street Journal, Google Finance, and Yahoo Finance. Ticker Nerd is not a registered financial, investment, legal or tax advisor and is not liable for any financial loss you may incur acting on any information provided by Ticker Nerd. By registering, you agree not to hold Ticker Nerd liable at any time or under any circumstances for your decisions, actions, or results.
